NCT04178967 · Interventional trial
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Dermatology and Skin Surgery Center · Exton, PA · Chester County
First posted
Registry updated
Added to the directory